Techpoint
6697
FISCO
3807
Reyuu Japan
9425
NCXX Group
6634
AGEHA
9330
Jefferies Adjusts Noile-Immune Biotech's Price Target to 440 Yen From 800 Yen, Keeps at Buy
Japanese Shares Hit 33,000 Mark Again as Yen Slips, BoJ Holds Rates Steady
Noile-Immune Biotech to Seek New Partnerships After Termination of Takeda License Deal; Shares Surge 23%
Noile-Immune Biotech Regains Rights to Solid Tumor Drug Candidates as Takeda Terminates License Deal